OSTX
OS Therapies Incorporated
0.8722
-0.04 (-4.48%)
52w low 0.5800
2.25 high
17.5% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 2.80M | 1.88M | 269.83K | 917.55K | 205.03K | |
| Receivables | -- | -- | -- | -- | -- | 3.10M | |
| Current Assets | -- | 3.55M | 2.32M | 332.91K | 917.55K | 3.64M | |
| Net PP&E | -- | 3.88K | 3.19K | 2.49K | 1.79K | 1.10K | |
| Total Assets | -- | 10.31M | 8.95M | 6.84M | 7.30M | 9.90M | |
| Current Liabilities | -- | 3.46M | 4.15M | 11.76M | 16.95M | 20.64M | |
| Total Debt | -- | -- | -- | -- | 1.34M | -- | |
| Total Liabilities | -- | 5.37M | 5.32M | 12.94M | 18.12M | 21.81M | |
| Retained Earnings | -- | -46.85M | -53.73M | -67.19M | -77.58M | -86.22M | |
| Shareholders Equity | -- | 4.94M | 3.64M | -6.10M | -10.82M | -11.91M | |
| Working Capital | -- | 95.94K | -1.82M | -11.43M | -16.04M | -17.00M | |
| Shares Outstanding | -- | 29.66M | 33.27M | 37.11M | 39.28M | 45.28M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--